All Roll Calls
Yes: 602 • No: 128
Sponsored By: Committee on Public Health and Welfare
Became Law
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
5 provisions identified: 2 benefits, 1 costs, 2 mixed.
Kansas patients can request experimental drugs, biological products, or devices made only for them using their genetic profile. This includes personalized gene therapies and vaccines. A treating physician must confirm a life-threatening or severely debilitating illness, and patients must consider all FDA-approved options. A Kansas-licensed physician must recommend treatment based on genetic or related biological analysis and document eligibility. Written consent must identify the treatment, explain approved options, and describe likely, best, and worst outcomes—including worsened symptoms or faster death. The patient, or a minor's parent or guardian, signs; the physician and an unaffiliated witness attest. Manufacturers must operate within facilities covered by federal human-subject protection assurances. Manufacturers can offer treatment free or charge manufacturing costs, but do not have to provide it. Kansas state officials, employees, and agents cannot block or try to block eligible patients' access.
Written consent must state that patients owe all treatment-related expenses; liability extends to their estate unless the manufacturer contract says otherwise. If a patient dies during treatment, heirs do not owe outstanding treatment debts or debts from losing insurance because of treatment. The estate may still owe those debts. The law adds no required insurance coverage or government payment, though health plans, administrators, and government agencies can cover costs. Existing required clinical-trial coverage stays unchanged, and hospitals and licensed facilities need not offer new services they have not approved. Consent must explain that payers and providers need not pay unless law or contract requires it. It must also warn that starting curative treatment may end hospice eligibility; eligibility can return after treatment ends if hospice criteria are met.
Covered facilities must notify patients or their estates and ask consent for uses of biological samples beyond the patient's personalized treatment. Before profiting from a product developed from a sample, the facility must disclose each potential commercial use and obtain consent. That consent must include profit sharing or another contract that benefits the patient or estate. The law sets no payment amount or sharing formula.
Kansas licensing boards cannot revoke, suspend, refuse to renew, or otherwise discipline licenses solely for recommending access to or treatment with these products. Entities responsible for Medicare certification cannot act against that certification solely because a provider recommends access. Counseling, advice, and recommendations consistent with medical standards of care do not violate the law. These protections do not require providers to recommend or provide treatment, or require Medicare coverage.
The law creates no private right to sue manufacturers or others involved in care for harm caused by these treatments when they follow the act in good faith and use reasonable care. This concerns the lawsuit right described by the act. It does not say that all other legal claims are barred.
Committee on Public Health and Welfare
Affiliation unavailable
There are no cosponsors for this bill.
All Roll Calls
Yes: 602 • No: 128
Senate vote • 4/23/2026
Yea: 36 Nay: 4
Yes: 36 • No: 4
Senate vote • 4/23/2026
Yea: 9 Nay: 31
Yes: 9 • No: 31
Senate vote • 4/23/2026
Yea: 40 Nay: 0
Yes: 40 • No: 0
Senate vote • 4/23/2026
Yea: 119 Nay: 3
Yes: 119 • No: 3
Senate vote • 4/23/2026
Yea: 97 Nay: 26
Yes: 97 • No: 26
Senate vote • 3/27/2025
Conference Committee Report was adopted
Yes: 40 • No: 0
House vote • 3/26/2025
Conference Committee Report was adopted
Yes: 119 • No: 3
House vote • 3/19/2025
Emergency Final Action - Passed as amended
Yes: 97 • No: 26
Senate vote • 2/19/2025
Emergency Final Action - Passed
Yes: 36 • No: 4
Senate vote • 2/19/2025
Committee of the Whole - Amendment by Sen. Cindy Holscher was rejected
Yes: 9 • No: 31
Enrolled and presented to Governor on Friday, April 4, 2025
Will become law without Governor's signature
Conference Committee Report was adopted; Yea 40, Nay 0
Conference committee report now available
Conference Committee Report was adopted; Yea 119, Nay 3, Absent 3
Motion to accede adopted; Rep. Will Carpenter, Rep. Ron Bryce and Rep. Susan Ruiz appointed as conferees
Nonconcurred with amendments; Conference Committee requested; appointed Sen. Beverly Gossage, Sen. William Clifford and Sen. Cindy Holscher
Committee of the Whole - Committee Report be adopted
Committee of the Whole - Be passed as amended
Motion to advance to Emergency Final Action adopted
Emergency Final Action - Passed as amended; Yea 97, Nay 26, Absent 2
Committee Report recommending bill be passed as amended by House Committee on Health and Human Services
Hearing: Friday, March 7, 2025, 1:30 PM — Room 112-N
Received and Introduced
Referred to House Committee on Health and Human Services
Committee of the Whole - Motion to Amend - Offered by Sen. Cindy Holscher
Committee of the Whole - Amendment by Sen. Cindy Holscher was rejected; Yea 9, Nay 31
Committee of the Whole - Be passed
Emergency Final Action - Passed; Yea 36, Nay 4
Committee Report recommending bill be passed by Senate Committee on Public Health and Welfare
Hearing: Friday, February 14, 2025, 8:30 AM — Room 142-S
Referred to Senate Committee on Public Health and Welfare
Introduced
Allowed to become law without signature; 2025 Kansas session laws, chapter 103
As Amended by House Committee
As Introduced
Enrolled
SB 430, Adding mitragynine to schedule I of the uniform controlled substances act and reconciling multiple amendments to certain statutes in the Kansas criminal code.
SB 82, Providing tax credits for expenditures for lockable gun and ammunition storage and the retail sale of higher ethanol blends of fuel, discontinuing the tax credit for qualified alternative-fueled motor vehicle property or fueling station expenditures, repealing the agritourism liability insurance, assistive technology contributions, declared disaster capital investment, owners promoting employment across Kansas and swine facility improvement tax credits and expanding the eligibility for applicable expenses under the child day care services assistance tax credit.
SB 300, Providing for the apportionment of business income by manufacturers of alcoholic liquor depending on whether the taxpayer is a qualifying Kansas investor or a general manufacturer and removing obsolete reference to global intangible low-taxed income provided for under the federal internal revenue code in determining Kansas adjusted gross income.
HB 2029, Reconciling multiple amendments to certain statutes.
HB 2018, Senate Substitute for HB 2018 by Committee on Federal and State Affairs - Creating the crime of interference with the conduct of a religious assembly, providing criminal penalties therefor and providing for a civil cause of action for damages.
HB 2036, Providing a Kansas income tax subtraction modification for certain amounts received as compensation for members of the armed forces.